NLRC4 promotes PANoptosis to overcome sorafenib resistance in hepatocellular carcinoma by competitively binding to BCLAF1 with TRIB3
收藏integrated proteome resources2026-05-09 收录
官方服务：
资源简介：
NLRC4 promotes PANoptosis to overcome sorafenib resistance in hepatocellular carcinoma by competitively binding to BCLAF1 with TRIB3
创建时间：
2026-05-08
